Cardiovascular effects of preparation CIBA 34,276-Ba and imipramine.
D000284:Administration, Oral; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000588:Amines / Q000008:administration & dosage; D000818:Animals; D000873:Anthracenes / Q000008:administration & dosage / Q000494:pharmacology*; D000928:Antidepressive Agents / Q000008:administration & dosage / Q000494:pharmacology*; D001794:Blood Pressure / Q000187:drug effects; D001952:Bridged-Ring Compounds / Q000008:administration & dosage / Q000494:pharmacology; D002302:Cardiac Output / Q000187:drug effects; D002415:Cats; D004285:Dogs; D006168:Guinea Pigs; D006339:Heart Rate / Q000187:drug effects; D006977:Hypertension, Renal; D007099:Imipramine / Q000008:administration & dosage / Q000494:pharmacology*; D007275:Injections, Intravenous; D008744:Methylamines / Q000494:pharmacology; D009119:Muscle Contraction / Q000187:drug effects; D051381:Rats; D013997:Time Factors
D000319:Adrenergic beta-Antagonists; D000588:Amines; D000873:Anthracenes; D000928:Antidepressive Agents; D001952:Bridged-Ring Compounds; D008744:Methylamines; D007099:Imipramine